🇺🇸 FDA
Patent

US 8740872

Magnetically-targeted treatment for cardiac disorders

granted A61KA61K9/0009A61K9/0019

Quick answer

US patent 8740872 (Magnetically-targeted treatment for cardiac disorders) held by The Board of Regents of the University of Oklahoma expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K9/0009, A61K9/0019, A61K9/5094, A61K9/5115